Form 8-K - Current report:
SEC Accession No. 0001023024-24-000100
Filing Date
2024-11-08
Accepted
2024-11-08 06:55:35
Documents
15
Period of Report
2024-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20241108.htm   iXBRL 8-K 27970
2 EX-99.1 anip-20241108xexx991.htm EX-99.1 424721
6 a1.jpg GRAPHIC 5505
  Complete submission text file 0001023024-24-000100.txt   613276

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20241108.xsd EX-101.SCH 1755
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20241108_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20241108_pre.xml EX-101.PRE 12491
17 EXTRACTED XBRL INSTANCE DOCUMENT ani-20241108_htm.xml XML 2787
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 241437941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)